2016
DOI: 10.1016/j.rceng.2016.01.005
|View full text |Cite
|
Sign up to set email alerts
|

B-type natriuretic peptide and acute heart failure: Fluid homeostasis, biomarker and therapeutics

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…In humans, the blood concentration of BNP is increased in patients with cardiac diseases due to mechanical stimuli (de Bold et al 1996 ). Therefore, the blood concentration of the natriuretic peptide and its N-terminal fragment (NT-pro-BNP) is used in human medicine as a diagnostic tool in patients presenting with acute dyspnoea for the identification of heart diseases and differentiation from primary diseases of the respiratory system (Torres-Courchoud and Chen 2016 ). It can also be used as an efficient prognostic marker for the risk of future cardiac events and mortality (Santaguida et al 2014 ).…”
Section: Introductionmentioning
confidence: 99%
“…In humans, the blood concentration of BNP is increased in patients with cardiac diseases due to mechanical stimuli (de Bold et al 1996 ). Therefore, the blood concentration of the natriuretic peptide and its N-terminal fragment (NT-pro-BNP) is used in human medicine as a diagnostic tool in patients presenting with acute dyspnoea for the identification of heart diseases and differentiation from primary diseases of the respiratory system (Torres-Courchoud and Chen 2016 ). It can also be used as an efficient prognostic marker for the risk of future cardiac events and mortality (Santaguida et al 2014 ).…”
Section: Introductionmentioning
confidence: 99%